In Brief: ConvaTec
This article was originally published in The Gray Sheet
Executive Summary
ConvaTec: Bristol-Meyers Squibb subsidiary opens manufacturing facility in Shenzhen, China, to produce ostomy care products for the Chinese market. The facility, Squibb-ConvaTec Medical Products, is a joint venture with Shenzhen China Associated Guangshen Pharmaceutical Company. China has an estimated 200,000 ostomy patients, a number anticipated to grow due to a "rise in the occurrence and diagnosis of colorectal cancer," BMS states...
You may also be interested in...
Aldeyra Hopes To Refile Dry Eye Drug Reproxalap Later In 2024
Following an FDA complete response letter last November, Aldeyra has agreed with the agency on a trial design to demonstrate efficacy in ocular discomfort, which the company can complete this year.
Colorado Price Cap Plan For Enbrel Draws Amgen Lawsuit; Cosentyx, Stelara ‘Affordability’ Reviews Pending
However, the state's recently formed prescription drug affordability board found Gilead’s Genvoya and Vertex’s Trikafta to be affordable.
Biden Administration Is Setting An Example For Safe AI Use In Federal Organizations
A new memorandum by the Director of the Office of Management and Budget initiated a government-wide policy that will appoint AI officers to all agencies to address risks for AI use and serve as an example for greater AI adoption.